{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:09:17Z","timestamp":1771034957486,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T00:00:00Z","timestamp":1510790400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["400-07-2013"],"award-info":[{"award-number":["400-07-2013"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2014SGR 680"],"award-info":[{"award-number":["2014SGR 680"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00213-017-4787-2","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T01:14:42Z","timestamp":1510794882000},"page":"709-717","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Peripheral endocannabinoid concentrations are not associated with verbal memory impairment during MDMA intoxication"],"prefix":"10.1007","volume":"235","author":[{"given":"E.","family":"Haijen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Farre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Olesti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Pizarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. G.","family":"Ramaekers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. P. C.","family":"Kuypers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,16]]},"reference":[{"issue":"8","key":"4787_CR1","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/sj.bjp.0704825","volume":"136","author":"D Braida","year":"2002","unstructured":"Braida D, Sala M (2002) Role of the endocannabinoid system in MDMA intracerebral self-administration in rats. British Journal of Pharmacology 136(8):1089\u20131092. \nhttps:\/\/doi.org\/10.1038\/sj.bjp.0704825","journal-title":"British Journal of Pharmacology"},{"issue":"2","key":"4787_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.phrs.2004.07.009","volume":"51","author":"D Braida","year":"2005","unstructured":"Braida D, Iosu\u00e8 S, Pegorini S, Sala M (2005) 3,4-Methylenedioxymethamphetamine-induced conditioned place preference (CPP) is mediated by the endocannabinoid system. Pharmacological Research 51(2):177\u2013182. \nhttps:\/\/doi.org\/10.1016\/j.phrs.2004.07.009","journal-title":"Pharmacological Research"},{"issue":"6","key":"4787_CR3","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1017\/S1355617702860131","volume":"8","author":"P Bright","year":"2002","unstructured":"Bright P, Jaldow E, Kopelman MD (2002) The National Adult Reading Test as a measure of premorbid intelligence: a comparison with estimates derived from demographic variables. Journal of the International Neuropsychological Society : JINS 8(6):847\u2013854. \nhttps:\/\/doi.org\/10.1017\/S1355617702860131","journal-title":"Journal of the International Neuropsychological Society : JINS"},{"issue":"6","key":"4787_CR4","doi-asserted-by":"publisher","first-page":"903","DOI":"10.2165\/00003495-199040060-00010","volume":"40","author":"RN Brogden","year":"1990","unstructured":"Brogden RN, Sorkin EM (1990) Ketanserin. Drugs 40(6):903\u2013949. \nhttps:\/\/doi.org\/10.2165\/00003495-199040060-00010","journal-title":"Drugs"},{"issue":"5","key":"4787_CR5","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.biopsych.2011.04.022","volume":"70","author":"A Busquets-Garcia","year":"2011","unstructured":"Busquets-Garcia A, Puighermanal E, Pastor A, de la Torre R, Maldonado R, Ozaita A (2011) Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses. Biological Psychiatry 70(5):479\u2013486. \nhttps:\/\/doi.org\/10.1016\/j.biopsych.2011.04.022","journal-title":"Biological Psychiatry"},{"issue":"5","key":"4787_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrn.2016.28","volume":"17","author":"HV Curran","year":"2016","unstructured":"Curran HV, Freeman TP, Mokrysz C, Lewis DA, Morgan CJ, Parsons LH (2016) Keep off the grass? Cannabis, cognition and addiction. Nat Rev Neurosci 17(5):293\u2013306. \nhttps:\/\/doi.org\/10.1038\/nrn.2016.28","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"4787_CR7","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1177\/0269881110376687","volume":"25","author":"GJ Dumont","year":"2011","unstructured":"Dumont GJ, van Hasselt JG, de Kam M, van Gerven JM, Touw DJ, Buitelaar JK, Verkes RJ (2011) Acute psychomotor, memory and subjective effects of MDMA and THC co-administration over time in healthy volunteers. Journal of psychopharmacology (Oxford, England) 25(4):478\u2013489. \nhttps:\/\/doi.org\/10.1177\/0269881110376687","journal-title":"Journal of psychopharmacology (Oxford, England)"},{"issue":"2","key":"4787_CR8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1177\/0269881106061153","volume":"20","author":"N Easton","year":"2006","unstructured":"Easton N, Marsden CA (2006) Ecstasy: are animal data consistent between species and can they translate to humans? J Psychopharmacol 20(2):194\u2013210. \nhttps:\/\/doi.org\/10.1177\/0269881106061153","journal-title":"J Psychopharmacol"},{"key":"4787_CR9","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1001\/archgenpsychiatry.2011.56","volume":"68","author":"D Erritzoe","year":"2011","unstructured":"Erritzoe D et al (2011) In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or \u201cecstasy\u201d) and hallucinogen users. Arch Gen Psychiatr 68:562\u2013576. \nhttps:\/\/doi.org\/10.1001\/archgenpsychiatry.2011.56","journal-title":"Arch Gen Psychiatr"},{"key":"4787_CR10","doi-asserted-by":"publisher","first-page":"18620","DOI":"10.1073\/pnas.0509591102","volume":"102","author":"G Gobbi","year":"2005","unstructured":"Gobbi G et al (2005) Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Nat Acad Sci U S A 102:18620\u201318625. \nhttps:\/\/doi.org\/10.1073\/pnas.0509591102","journal-title":"Proc Nat Acad Sci U S A"},{"key":"4787_CR11","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1111\/j.1476-5381.2011.01819.x","volume":"166","author":"AR Green","year":"2012","unstructured":"Green AR, King MV, Shortall SE, Fone KCF (2012) Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans. Br J Pharmacol 166:1523\u20131536. \nhttps:\/\/doi.org\/10.1111\/j.1476-5381.2011.01819.x","journal-title":"Br J Pharmacol"},{"key":"4787_CR12","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.neuropharm.2011.02.016","volume":"61","author":"S Haj-Dahmane","year":"2011","unstructured":"Haj-Dahmane S, Shen R-Y (2011) Modulation of the serotonin system by endocannabinoid signaling. Neuropharmacology 61:414\u2013420. \nhttps:\/\/doi.org\/10.1016\/j.neuropharm.2011.02.016","journal-title":"Neuropharmacology"},{"issue":"1","key":"4787_CR13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1210\/jc.2014-3455","volume":"100","author":"EC Hanlon","year":"2015","unstructured":"Hanlon EC, Tasali E, Leproult R, Stuhr KL, Doncheck E, de Wit H, Hillard CJ, van Cauter E (2015) Circadian rhythm of circulating levels of the endocannabinoid 2-arachidonoylglycerol. J Clin Endocrinol Metab 100(1):220\u2013226. \nhttps:\/\/doi.org\/10.1210\/jc.2014-3455","journal-title":"J Clin Endocrinol Metab"},{"key":"4787_CR14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/bf00981135","volume":"31","author":"J Heykants","year":"1986","unstructured":"Heykants J, Van Peer A, Woestenborghs R, Gould S, Mills J (1986) Pharmacokinetics of ketanserin and its metabolite ketanserin-ol in man after intravenous, intramuscular and oral administration. Eur J Clin Pharmacol 31:343\u2013350. \nhttps:\/\/doi.org\/10.1007\/bf00981135","journal-title":"Eur J Clin Pharmacol"},{"key":"4787_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1517\/14728210902736568","volume":"14","author":"DR Janero","year":"2009","unstructured":"Janero DR, Makriyannis A (2009) Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis. Expert Opin Emerg Drugs 14:43\u201365. \nhttps:\/\/doi.org\/10.1517\/14728210902736568","journal-title":"Expert Opin Emerg Drugs"},{"issue":"3","key":"4787_CR16","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1210\/jc.2010-2028","volume":"96","author":"R Jumpertz","year":"2011","unstructured":"Jumpertz R, Guijarro A, Pratley RE, Piomelli D, Krakoff J (2011) Central and peripheral endocannabinoids and cognate Acylethanolamides in humans: association with race, adiposity, and energy expenditure. J Clin Endocrinol Metab 96(3):787\u2013791. \nhttps:\/\/doi.org\/10.1210\/jc.2010-2028","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"4787_CR17","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1177\/0269881105056670","volume":"19","author":"KPC Kuypers","year":"2005","unstructured":"Kuypers KPC, Ramaekers JG (2005) Transient memory impairment after acute dose of 75 mg 3.4-methylenedioxymethamphetamine. J Psychopharmacol 19(6):633\u2013639. \nhttps:\/\/doi.org\/10.1177\/0269881105056670","journal-title":"J Psychopharmacol"},{"issue":"3","key":"4787_CR18","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1476-5381.2012.02196.x","volume":"168","author":"KPC Kuypers","year":"2013","unstructured":"Kuypers KPC, de la Torre R, Farre M, Pujadas M, Ramaekers JG (2013) Inhibition of MDMA-induced increase in cortisol does not prevent acute impairment of verbal memory. British Journal of Pharmacology 168(3):607\u2013617. \nhttps:\/\/doi.org\/10.1111\/j.1476-5381.2012.02196.x","journal-title":"British Journal of Pharmacology"},{"issue":"2","key":"4787_CR19","doi-asserted-by":"publisher","first-page":"e0149438","DOI":"10.1371\/journal.pone.0149438","volume":"11","author":"KP Kuypers","year":"2016","unstructured":"Kuypers KP, Theunissen e1, van Wel JH, de Sousa Fernandes Perna EB, Linssen A, Sambeth A, Schultz BG, Ramaekers JG (2016) Verbal memory impairment in polydrug ecstasy users: a clinical perspective. PloS One 11(2):e0149438. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0149438","journal-title":"PloS One"},{"key":"4787_CR20","doi-asserted-by":"publisher","unstructured":"Kuypers KPC, de la Torre R, Farre M, Pizarro N, Xicota L, Ramaekers JG (2017) MDMA-induced indifference to negative sounds is mediated by the 5-HT2A receptor Psychopharmacology (Berl). \nhttps:\/\/doi.org\/10.1007\/s00213-017-4699-1","DOI":"10.1007\/s00213-017-4699-1"},{"key":"4787_CR21","unstructured":"Mulder-Hajonides van der Meulen WREH, Wijnberg JR, Hollanders JJ, De Diana I, Hoofdakker R (1980) Measurement of subjective sleep quality. Paper presented at the Fifth European Congress on Sleep Research, Amsterdam"},{"key":"4787_CR22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.lfs.2005.12.028","volume":"79","author":"E Murillo-Rodriguez","year":"2006","unstructured":"Murillo-Rodriguez E, Desarnaud F, Prospero-Garcia O (2006) Diurnal variation of arachidonoylethanolamine, palmitoylethanolamide and oleoylethanolamide in the brain of the rat. Life Sci 79:30\u201337. \nhttps:\/\/doi.org\/10.1016\/j.lfs.2005.12.028","journal-title":"Life Sci"},{"key":"4787_CR23","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/npp.2009.158","volume":"35","author":"Y Nawata","year":"2010","unstructured":"Nawata Y, Hiranita T, Yamamoto T (2010) A cannabinoid CB(1) receptor antagonist ameliorates impairment of recognition memory on withdrawal from MDMA (ecstasy). Neuropsychopharmacology 35:515\u2013520. \nhttps:\/\/doi.org\/10.1038\/npp.2009.158","journal-title":"Neuropsychopharmacology"},{"key":"4787_CR24","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1111\/j.1471-4159.2006.04173.x","volume":"99","author":"JC Parrish","year":"2006","unstructured":"Parrish JC, Nichols DE (2006) Serotonin 5-HT(2A) receptor activation induces 2-arachidonoylglycerol release through a phospholipase c-dependent mechanism. J Neurochem 99:1164\u20131175. \nhttps:\/\/doi.org\/10.1111\/j.1471-4159.2006.04173.x","journal-title":"J Neurochem"},{"key":"4787_CR25","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1194\/jlr.D043794","volume":"55","author":"A Pastor","year":"2014","unstructured":"Pastor A, Farr\u00e9 M, Fit\u00f3 M, Fernandez-Aranda F, de la Torre R (2014) Analysis of ECs and related compounds in plasma: artifactual isomerization and ex vivo enzymatic generation of 2-MGs. J Lipid Res 55:966\u2013977. \nhttps:\/\/doi.org\/10.1194\/jlr.D043794","journal-title":"J Lipid Res"},{"issue":"4","key":"4787_CR26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2165\/00003088-199120040-00002","volume":"20","author":"B Persson","year":"1991","unstructured":"Persson B, Heykants J, Hedner T (1991) Clinical pharmacokinetics of ketanserin. Clinical Pharmacokinetics 20(4):263\u2013279. \nhttps:\/\/doi.org\/10.2165\/00003088-199120040-00002","journal-title":"Clinical Pharmacokinetics"},{"key":"4787_CR27","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0163-7258(97)82001-3, 2","volume":"74","author":"RG Pertwee","year":"1997","unstructured":"Pertwee RG (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74:129\u2013180. \nhttps:\/\/doi.org\/10.1016\/S0163-7258(97)82001-3, 2","journal-title":"Pharmacol Ther"},{"issue":"3","key":"4787_CR28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/jat\/26.3.157","volume":"26","author":"N Pizarro","year":"2002","unstructured":"Pizarro N, Ortuno J, Farre M, Hernandez-Lopez C, Pujadas M, Llebaria A, Joglar J, Roset PN, Mas M, Segura J, Cami J, de la Torre R (2002) Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis. J Anal Toxicol 26(3):157\u2013165. \nhttps:\/\/doi.org\/10.1093\/jat\/26.3.157","journal-title":"J Anal Toxicol"},{"key":"4787_CR29","doi-asserted-by":"publisher","unstructured":"Puxty DJ, Ramaekers JG, de la Torre R, Farr\u00e9 M, Pizarro N, Pujadas M, Kuypers KPC (2017) MDMA-induced dissociative state not mediated by the 5-HT2A receptor. Front Pharmacol Neuropharmacol 8(455). \nhttps:\/\/doi.org\/10.3389\/fphar.2017.00455","DOI":"10.3389\/fphar.2017.00455"},{"issue":"7","key":"4787_CR30","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1038\/npp.2008.219","volume":"34","author":"JG Ramaekers","year":"2009","unstructured":"Ramaekers JG, Kuypers KPC, Wingen M, Heinecke A, Formisano E (2009) Involvement of inferior parietal lobules in prospective memory impairment during acute MDMA (Ecstasy) intoxication: an event-related fMRI study. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol 34(7):1641\u20131648. \nhttps:\/\/doi.org\/10.1038\/npp.2008.219","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"issue":"1","key":"4787_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/bf00544018","volume":"25","author":"IW Reimann","year":"1983","unstructured":"Reimann IW, Okonkwo PO, Klotz U (1983) Pharmacokinetics of ketanserin in man. Eur J Clin Pharmacol 25(1):73\u201376. \nhttps:\/\/doi.org\/10.1007\/bf00544018","journal-title":"Eur J Clin Pharmacol"},{"key":"4787_CR32","volume-title":"The clinical examination in psychology\/L'examen clinique en psychologie","author":"A Rey","year":"1958","unstructured":"Rey A (1958) The clinical examination in psychology\/L'examen clinique en psychologie. Presses Universitaires De France, Paris"},{"key":"4787_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.edurev.2010.12.001","volume":"6","author":"JTE Richardson","year":"2011","unstructured":"Richardson JTE (2011) Eta squared and partial eta squared as measures of effect size in educational research. Educ Res Rev 6:135\u2013147. \nhttps:\/\/doi.org\/10.1016\/j.edurev.2010.12.001","journal-title":"Educ Res Rev"},{"issue":"2","key":"4787_CR34","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00213-007-0879-8","volume":"195","author":"P Robledo","year":"2007","unstructured":"Robledo P, Trigo JM, Panayi F, de la Torre R, Maldonado R (2007) Behavioural and neurochemical effects of combined MDMA and THC administration in mice. Psychopharmacology 195(2):255\u2013264. \nhttps:\/\/doi.org\/10.1007\/s00213-007-0879-8","journal-title":"Psychopharmacology"},{"key":"4787_CR35","first-page":"15","volume":"22","author":"B Schmand","year":"1991","unstructured":"Schmand B, Bakker D, Saan R, Louman J (1991) De Nederlandse Leestest voor Volwassenen: een maat voor het premorbide intelligentieniveau. Tijdschrift voor Gerontologie en Geriatrie 22:15\u201319","journal-title":"Tijdschrift voor Gerontologie en Geriatrie"},{"key":"4787_CR36","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/0028-3908(94)90077-9","volume":"33","author":"AL Sharpley","year":"1994","unstructured":"Sharpley AL, Elliott JM, Attenburrow MJ, Cowen PJ (1994) Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors. Neuropharmacology 33:467\u2013471. \nhttps:\/\/doi.org\/10.1016\/0028-3908(94)90077-9","journal-title":"Neuropharmacology"},{"key":"4787_CR37","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.neuropharm.2014.03.008","volume":"87","author":"EB Sousa Fernandes Perna de","year":"2014","unstructured":"de Sousa Fernandes Perna EB, Theunissen EL, Kuypers KPC, Heckman P, de la Torre R, Farre M, Ramaekers JG (2014) Memory and mood during MDMA intoxication, with and without memantine pretreatment. Neuropharmacology 87:198\u2013205. \nhttps:\/\/doi.org\/10.1016\/j.neuropharm.2014.03.008","journal-title":"Neuropharmacology"},{"issue":"2","key":"4787_CR38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/00007691-200404000-00009","volume":"26","author":"R Torre de la","year":"2004","unstructured":"de la Torre R, Farr\u00e9 M, Roset PN, Pizarro N, Abanades S, Segura M, Segura J, Cam\u00ed J (2004) Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition. Ther Drug Monit 26(2):137\u2013144. \nhttps:\/\/doi.org\/10.1097\/00007691-200404000-00009","journal-title":"Ther Drug Monit"},{"key":"4787_CR39","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s00018-003-3453-5","volume":"61","author":"M Valenti","year":"2004","unstructured":"Valenti M, Vigan\u00f2 D, Casico MG, Rubino T, Steardo L, Parolaro D, Di Marzo V (2004) Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain. Cell Mol Life Sci CMLS 61:945\u2013950. \nhttps:\/\/doi.org\/10.1007\/s00018-003-3453-5","journal-title":"Cell Mol Life Sci CMLS"},{"issue":"40","key":"4787_CR40","doi-asserted-by":"publisher","first-page":"7081","DOI":"10.2174\/138161281940131209144331","volume":"19","author":"O Valverde","year":"2013","unstructured":"Valverde O, Rodriguez-Arias M (2013) Modulation of 3,4-methylenedioxymethamphetamine effects by endocannabinoid system. Curr Pharm Des 19(40):7081\u20137091. \nhttps:\/\/doi.org\/10.2174\/138161281940131209144331","journal-title":"Curr Pharm Des"},{"issue":"3","key":"4787_CR41","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/j.1476-5381.2010.00790.x","volume":"160","author":"LK Vaughn","year":"2010","unstructured":"Vaughn LK, Denning G, Stuhr KL, Hd W, Hill MN, Hillard CJ (2010) Endocannabinoid signalling: has it got rhythm? Br J Pharmacol 160(3):530\u2013543. \nhttps:\/\/doi.org\/10.1111\/j.1476-5381.2010.00790.x","journal-title":"Br J Pharmacol"},{"issue":"17","key":"4787_CR42","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","volume":"9","author":"FX Vollenweider","year":"1998","unstructured":"Vollenweider FX, Vollenweider-Scherpenhuyzen MF, B\u00e4bler A, Vogel H, Hell D (1998) Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport 9(17):3897\u20133902. \nhttps:\/\/doi.org\/10.1097\/00001756-199812010-00024","journal-title":"Neuroreport"},{"key":"4787_CR43","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1038\/npp.2011.80","volume":"36","author":"JHP Wel van","year":"2011","unstructured":"van Wel JHP, Kuypers KPC, Theunissen EL, Bosker WM, Bakker K, Ramaekers JG (2011) Blockade of 5-HT2 receptor selectively prevents MDMA induced verbal memory impairment. Neuropsychopharmacology 36:1932\u20131939. \nhttps:\/\/doi.org\/10.1038\/npp.2011.80","journal-title":"Neuropsychopharmacology"},{"key":"4787_CR44","doi-asserted-by":"publisher","first-page":"e40187","DOI":"10.1371\/journal.pone.0040187","volume":"7","author":"JHP Wel van","year":"2012","unstructured":"van Wel JHP, Kuypers KPC, Theunissen EL, Bosker WM, Bakker K, Ramaekers JG (2012) Effects of acute MDMA intoxication on mood and impulsivity: role of the 5-HT2 and 5-HT1 receptors. PLoS One 7:e40187. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0040187","journal-title":"PLoS One"},{"issue":"8","key":"4787_CR45","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/sj.npp.1300692","volume":"30","author":"JM Young","year":"2005","unstructured":"Young JM, McGregor IS, Mallet PE (2005) Co-administration of THC and MDMA (\u2018ecstasy\u2019) synergistically disrupts memory in rats. Neuropsychopharmacology 30(8):1475\u20131482. \nhttps:\/\/doi.org\/10.1038\/sj.npp.1300692","journal-title":"Neuropsychopharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-017-4787-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-017-4787-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-017-4787-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T23:03:18Z","timestamp":1519167798000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-017-4787-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,16]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["4787"],"URL":"https:\/\/doi.org\/10.1007\/s00213-017-4787-2","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,16]]}}}